EOS imaging receives Chinese FDA approval for EOS system: 3 things to know

EOS imaging received approval from the China Food and Drug Administration to market the EOS system.

Advertisement

Here are three things to know:

 

1. The EOS system is already in clinical use in several markets in the Asia-Pacific region, including Hong Kong, Singapore, Japan, Australia and Vietnam.

 

2. With this new approval, the EOS system can be marketed in 51 countries worldwide.

 

3. The EOS system is a medical imaging system focused on osteoarticular pathologies and orthopedics.

 

More articles on devices:
Medtech, Life Spine, Zimmer Biomet & more: 20 key notes
Amedica’s product revenue drops 15% in 2015 to $19.5M: 7 key notes
Maxx Orthopedics’ Freedom PCK System successfully implanted in 1st surgeries: 4 points

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

160 ambulatory leaders just ranked the EHR as the single system most overdue for AI reinvention

Tuesday, August 11
12:00 PM - 1:00 PM CDT

Presenter: Gautam Shah, MBA, FACHDM, NextGen Healthcare

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.